The Lancet: January 28, 2011
Do baseline CRP concentrations influence the effect of statins in reducing cardiovascular risk? (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 28, 2011 Category: Journals (General) Authors: The Lancet Source Type: podcasts
Einstein On: Diabetes, Dr. Joel Zonszein
Joel Zonszein, M.D., professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center, discusses alarming changes he has observed in the severity of type 2 diabetes during his more than three decades of treating patients. Dr. Zonszein explores the disturbing trend of young people, many of them teens, developing an aggressive form of type 2 diabetes that often is accompanied by high blood pressure, high cholesterol and fatty liver disease. He also addresses the special challenges of type 1 diabetics and suggests best practices for managing both types of the disease. Hosted...
Source: Einstein On... - January 21, 2011 Category: Universities & Medical Training Authors: Albert Einstein College of Medicine Source Type: podcasts
The Lancet: July 30, 2010
Discussion of HDL cholesterol as an indicator of cardiovascular risk after lipid-lowering therapy to reduce LDL cholesterol. (Source: Listen to The Lancet)
Source: Listen to The Lancet - July 30, 2010 Category: Journals (General) Authors: The Lancet Source Type: podcasts
JAMA: 2010-05-26, Vol. 303, No. 20, Author in the Room™ Audio Interview
Interview with Kenneth J. Mukamal, MD, MPH, MA, author of A 42-Year-Old Man Considering Whether to Drink Alcohol for His Health. Summary Points:1. Careful alcohol histories are needed for all patients, particularly to identify binge drinking, which is frequent among moderate and especially younger drinkers. 2. Even moderate alcohol consumption has important and plausible health effects based on short-term trials and observational studies, including lower risk of heart disease presumably via higher HDL-cholesterol and higher risk of breast cancer (presumably via higher levels of estrone and DHEA sulfates). 3. Given these po...
Source: JAMA Author in the Room - July 23, 2010 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2010-05-26, Vol. 303, No. 20, Author in the Room ™ Audio Interview
Interview with Kenneth J. Mukamal, MD, MPH, MA, author of A 42-Year-Old Man Considering Whether to Drink Alcohol for His Health. Summary Points:1. Careful alcohol histories are needed for all patients, particularly to identify binge drinking, which is frequent among moderate and especially younger drinkers. 2. Even moderate alcohol consumption has important and plausible health effects based on short-term trials and observational studies, including lower risk of heart disease presumably via higher HDL-cholesterol and higher risk of breast cancer (presumably via higher levels of estrone and DHEA sulfates). 3. Given these po...
Source: JAMA Author in the Room - July 23, 2010 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2008-12-17, Vol. 300, No. 23, Author in the Room™ Audio Interview
Interview with David J.A. Jenkins, MD, PhD, author of Effect of a Low Glycemic Index or a High Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial. Summary Points: 1. Drugs such as the a–glucosidase inhibitor acarbose, which reduces the rate of digestion and absorption of carbohydrate and so flattens the post prandial glycemic response, have been shown to improve diabetes control, reduce the risk of developing hypertension, and lower the risk for cardiovascular disease. 2. Can a selection of more slowly digested carbohydrate foods achieve qualitatively similar benefits to drugs? Current data suggest that selection o...
Source: JAMA Author in the Room - January 22, 2009 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2008-12-17, Vol. 300, No. 23, Author in the Room ™ Audio Interview
Interview with David J.A. Jenkins, MD, PhD, author of Effect of a Low Glycemic Index or a High Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial. Summary Points: 1. Drugs such as the a–glucosidase inhibitor acarbose, which reduces the rate of digestion and absorption of carbohydrate and so flattens the post prandial glycemic response, have been shown to improve diabetes control, reduce the risk of developing hypertension, and lower the risk for cardiovascular disease. 2. Can a selection of more slowly digested carbohydrate foods achieve qualitatively similar benefits to drugs? Current data suggest that selection o...
Source: JAMA Author in the Room - January 22, 2009 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
The Lancet: July 18, 2008
Risk markers of coronary heart disease: apolipoproteins and cholesterol as indices of risk for myocardial infarction are assessed in a large case-control study, and discussed in a podcast. (Source: Listen to The Lancet)
Source: Listen to The Lancet - July 18, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
JAMA: 2008-04-09, Vol. 299, No. 14, Author in the Room ™ Audio Interview
Interview with Barbara V. Howard, PhD, author of Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial. Summary Points: 1. Both standard and aggressive targets for blood pressure and LDL cholesterol in individuals with diabetes can be achieved and are safe. 2. Aggressive targets were associated with regression in IMT and greater decrease in LV mass, but long term data are needed to determine if they will result in improvement in clinical events. 3. Aggressive targets for blood pressure and LDL cholesterol may be considered on an individual basis. (Source: ...
Source: JAMA Author in the Room - May 23, 2008 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2008-04-09, Vol. 299, No. 14, Author in the Room™ Audio Interview
Interview with Barbara V. Howard, PhD, author of Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial. Summary Points: 1. Both standard and aggressive targets for blood pressure and LDL cholesterol in individuals with diabetes can be achieved and are safe. 2. Aggressive targets were associated with regression in IMT and greater decrease in LV mass, but long term data are needed to determine if they will result in improvement in clinical events. 3. Aggressive targets for blood pressure and LDL cholesterol may be considered on an individual basis. (Source: ...
Source: JAMA Author in the Room - May 23, 2008 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
The Lancet: February 08, 2008
Rhona MacDonald interviews Manjinder Sandhu about a genome-wide association study which looks at LDL-cholesterol concentrations and a novel locus on chromosome 1p13.3. Dr Sandhu also explains more about the principles of genome-wide studies and also discusses their potential to influence clinical practice. (Source: Listen to The Lancet)
Source: Listen to The Lancet - February 8, 2008 Category: Journals (General) Authors: The Lancet Source Type: podcasts
